TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.

Paulo R L Machado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.